title: Gonadotrophin-releasing hormone agonists, diabetes and cardiovascular disease in men with prostate cancer: which metabolic syndrome?
authors.affiliation: Hematology-Oncology Division, Massachusetts General Hospital, Boston, MA 02114, USA. smith.matthew@mgh.harvard.edu
authors.forename: Matthew R
authors.initials: MR
authors.lastname: Smith
authors.forename: A James
authors.initials: AJ
authors.lastname: O'Malley
authors.forename: Nancy L
authors.initials: NL
authors.lastname: Keating
mesh_terms: D002318:Cardiovascular Diseases / Q000139:chemically induced*; D003430:Cross-Sectional Studies; D003924:Diabetes Mellitus, Type 2 / Q000139:chemically induced*; D007987:Gonadotropin-Releasing Hormone / Q000819:agonists*; D006801:Humans; D008297:Male; D024821:Metabolic Syndrome / Q000139:chemically induced*; D011471:Prostatic Neoplasms / Q000188:drug therapy*; D012307:Risk Factors
chemical_list: D007987:Gonadotropin-Releasing Hormone